SCHEMBL29557451

SCHEMBL29557451

Cc1ccc([C@@H]2CC=CCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.38
MAP1LC3B Q9GZQ8 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
TP53 P04637 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
ATM Q13315 1/20 0.35
SLC6A2 P23975 3/20 0.34
SLC6A3 Q01959 3/20 0.34
RAB9A P51151 3/20 0.34
HTT P42858 2/20 0.34
ACHE P22303 2/20 0.33
CYP2D6 P10635 1/20 0.33
SLC6A4 P31645 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KCNH2 Q12809 1/20 0.33
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27545971 0.80 HPGD (0.42) ALDH1A1SMN1; SMN2SLC6A2SLC6A3CYP2D6
SCHEMBL27572133 0.79 SLC6A2 (0.55) SLC18A3ALDH1A1SMN1; SMN2SLC6A2SLC6A3
SCHEMBL29557795 0.79 KDM1A (0.38) MAP1LC3BALDH1A1LMNAATMSLC6A2
SCHEMBL29558540 0.79 SLC6A2 (0.55) SLC18A3ALDH1A1SMN1; SMN2SLC6A2SLC6A3
SCHEMBL8288153 0.79 ESR2 (0.50) ALDH1A1MAPTHTTCYP2D6
SCHEMBL27546048 0.79 DRD2 (0.45) ALDH1A1MAPTSMN1; SMN2RAB9ATDP1
SCHEMBL35975 0.78 SLC18A3 (0.45) SLC18A3MAPTCYP2D6
SCHEMBL29557767 0.78 SLC18A3 (0.45) SLC18A3MAPTCYP2D6
SCHEMBL28304250 0.78 SLC18A3 (0.45) SLC18A3MAPTCYP2D6
SCHEMBL4069248 0.76 SLC18A3 (0.44) SLC18A3MAP1LC3BALDH1A1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057765-A 3-aryl-4-amido-bicyclo [4,5,0] hydroxamic acids as HDAC inhibitors 瓦洛健康股份有限公司 2022-02-18 CN disclosed